The EANcore COVID-19 inatitive has launched a survey on neurological symptoms in COVID-19 patients.

EAN Scientific Panel Coma and Chronic Disorders of Consciousness The growing emergency due to the Covid-19 pandemic has rapidly and abruptly stressed health systems in all involved countries. Post-acute rehabilitation wards are exposed to understandable pressure from intensive care units… Continue Reading

In view of the challenges of the current Corona virus (COVID-19) pandemic and with the aim of protecting both patients and ultrasound providers (physicians, sonographers, allied professionals), the European Academy of Neurology Scientific Panel on Neurosonology is issuing the following… Continue Reading

At present, the Covid-19 pandemic is the focus of the global community and an all-consuming threat to the health care systems all across Europe. Resources and medical staff are reallocated, and planned medical activities are delayed or cancelled. Covid-19 poses… Continue Reading

06. April 2020 Coronavirus Disease 2019 (COVID-19) typically causes fever, pulmonary and respiratory symptoms as well as gastrointestinal symptoms in the form of diarrhoea. The disease may develop as pneumonia and acute respiratory distress syndrome, which may cause death. Neurological… Continue Reading

Released on April 3rd, 2020 To our knowledge, there is currently no evidence on how and if Corona Virus Disease 2019 (COVID-19) affects people with rare neurological diseases, mainly neurogenetics (NGDs). A recent (April 3rd) research on PubMed did not… Continue Reading

We are experiencing an unprecedented situation that no one had imagined or prepared for which has hit Europe during a period of prosperity, and the whole world. COVID-19 has come as a shock. In this context, headache services have to… Continue Reading

Neurologists stay aware of COVID-19 brain stem involvement The major clinical manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) infection are due to pulmonary complications. The majority of the patients so far in the COVID-19 pandemic had milder symptoms… Continue Reading

Cutaneous silent periods Cutaneous silent period is a useful, although underestimated tool for the clinical assessment of poly neuropathy as well as other neurological condition. This review provides an up to date on the physiology and methodology for its use… Continue Reading

As the CoVID-19 pandemic spreads across Europe and the world, in response the European Academy of Neurology is launching EANcore CoVID-19. This resource aims to help neurologists in Europe and beyond prepare for and manage the challenges this global crisis is bringing.

The new Corona virus disease 2019 (COVID-19) has drastically changed the world as we know it. Every aspect of our lives has been modified to adapt ourselves and to prevent the spread of this novel coronavirus (SARS-CoV-2). According to the World Health Organization (WHO), 1 279 722 confirmed cases have been reported worldwide with more than 72 616 deaths (as of 7 April 2020). Africa is the least affected region (10,260 confirmed cases and 492 deaths). However, this number may be underestimated and is continuing to rise relentlessly. Thus, Africa is facing the biggest challenge of the 21st century: making health as a priority. Scientific societies, national and international health authorities have to work together to strengthen the fight against SARS-CoV-2 and COVID-19.

Neuromuscular patients management in the COVID era Neuromuscular diseases are a group of heterogenic rare conditions, that can be due to a genetic cause, inflammatory processes or dysimmune disorders. Pathogenic processes can affect motor neurons, peripheral nerves, neuromuscular junction, or… Continue Reading

Due to the CoVID-19 pandemic spread, most outpatient facilities have been strictly regulated, thus making it difficult for many patients suffering from chronic pain to access treatment. During this tough period, all pain physicians, including neurologists, are working to find… Continue Reading

The Covid-19 global pandemic is having a dramatic impact on many chronic conditions including those affecting neurological patients and among them those with movement disorders. In many cases, to protect vulnerable movement disorders patients from becoming infected, appointments have been… Continue Reading

Specific challenges at present regarding Covid-19 and how these are being addressed
Highly pathogenic coronavirus infections are well-established sources of previous epidemics (severe acute respiratory syndrome coronavirus: SARS‐CoV, Middle East respiratory syndrome coronavirus: MERS‐CoV). Of interest, the novel coronavirus named… Continue Reading